Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McGovern

Showing results (141-150 of 275) with videos related to

Pageof 28
Sort By:
Frontiers in Immunology|March 13, 2024
Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-αElizabeth A Spencer, Marla C Dubinsky, Michael A Kamm, et al.
Frontiers in Immunology|March 13, 2024
Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-αElizabeth A Spencer, Marla C Dubinsky, Michael A Kamm, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 9, 2017
A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease PatientsJonathan P Jacobs, Maryam Goudarzi, Namita Singh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2017
Myeloid ATG16L1 Facilitates Host-Bacteria Interactions in Maintaining Intestinal HomeostasisHong Zhang, Libo Zheng, Dermot P B McGovern, et al.
Inflammatory Bowel Diseases|May 19, 2015
Combined Immunosuppression Impairs Immunogenicity to Tetanus and Pertussis Vaccination Among Patients with Inflammatory Bowel DiseaseSeper Dezfoli, Henry A Horton, Nattapaun Thepyasuwan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2023
HLA-DQA1∗05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysisVirginia Solitano, Antonio Facciorusso, Dermot P B McGovern, et al.
Inflammatory Bowel Diseases|September 29, 2023
Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel DiseaseYoo Jin Lee, Dalin Li, Angela Mujukian, et al.
Gastroenterology|October 1, 2013
Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of Crohn's diseaseKelli L VanDussen, Ta-Chiang Liu, Dalin Li, et al.
Digestive Diseases and Sciences|November 28, 2023
Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn's Disease (CD)Phillip Gu, Shishir Dube, YooJin Lee, et al.
International Journal of Molecular Sciences|September 28, 2023
A Paratope-Enhanced Method to Determine Breadth and Depth TCR Clonal Metrics of the Private Human T-Cell Vaccine Response after SARS-CoV-2 VaccinationDalin Li, Ana Jimena Pavlovitch-Bedzyk, Joseph E Ebinger, et al.
Pageof 28

Showing results (141-150 of 275) with videos related to

Sort By:
Pageof 28
Frontiers in Immunology|March 13, 2024
Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-αElizabeth A Spencer, Marla C Dubinsky, Michael A Kamm, et al.
Frontiers in Immunology|March 13, 2024
Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-αElizabeth A Spencer, Marla C Dubinsky, Michael A Kamm, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 9, 2017
A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease PatientsJonathan P Jacobs, Maryam Goudarzi, Namita Singh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2017
Myeloid ATG16L1 Facilitates Host-Bacteria Interactions in Maintaining Intestinal HomeostasisHong Zhang, Libo Zheng, Dermot P B McGovern, et al.
Inflammatory Bowel Diseases|May 19, 2015
Combined Immunosuppression Impairs Immunogenicity to Tetanus and Pertussis Vaccination Among Patients with Inflammatory Bowel DiseaseSeper Dezfoli, Henry A Horton, Nattapaun Thepyasuwan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2023
HLA-DQA1∗05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysisVirginia Solitano, Antonio Facciorusso, Dermot P B McGovern, et al.
Inflammatory Bowel Diseases|September 29, 2023
Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel DiseaseYoo Jin Lee, Dalin Li, Angela Mujukian, et al.
Gastroenterology|October 1, 2013
Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of Crohn's diseaseKelli L VanDussen, Ta-Chiang Liu, Dalin Li, et al.
Digestive Diseases and Sciences|November 28, 2023
Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn's Disease (CD)Phillip Gu, Shishir Dube, YooJin Lee, et al.
International Journal of Molecular Sciences|September 28, 2023
A Paratope-Enhanced Method to Determine Breadth and Depth TCR Clonal Metrics of the Private Human T-Cell Vaccine Response after SARS-CoV-2 VaccinationDalin Li, Ana Jimena Pavlovitch-Bedzyk, Joseph E Ebinger, et al.
Pageof 28